This year’s survey provided a better understanding of how those in the medical device industry can continuously improve their processes in an effort to stay in front of trends and create a competitive advantage.
Cincinnati, Ohio (PRWEB) October 14, 2014
Seapine Software, a leading provider of process-centric product development solutions, has released results of its 2014 State of Medical Device Development Survey. The online survey, which was conducted by Seapine for the third year, polled nearly 500 medical device development professionals between June 1 and August 30, 2014.
“The medical device industry is under increased pressure to reduce time- and cost-to-market as regulatory requirements continue to mount and cost-of-care is receiving greater scrutiny,” said Rick Riccetti, President and CEO of Seapine Software. “In addition to some interesting data points that caught us by surprise, this year’s survey provided a better understanding of how those in the medical device industry can continuously improve their processes in an effort to stay in front of trends and create a competitive advantage.”
The report, available for download here, provides insight into survey results, focusing on:
- How risk is being managed
- What areas in the development lifecycle need more visibility
- Which development activities are the most time-consuming
- What prevents team members from improving development processes
The 2014 Medical Device Development report is available now, and can be downloaded at: http://bit.ly/1slHX6C.
About Seapine Software
With more than 8,500 customers worldwide, Seapine Software, Inc. is a leading provider of process-centric product development solutions. Headquartered in Cincinnati, Ohio, with offices in Europe, Asia-Pacific and Africa, Seapine’s development solutions help organizations ensure the consistent release of high quality products, while providing traceability, metrics and reporting and compliance.
For more information, visit http://www.seapine.com or follow the company on Facebook, LinkedIn and Twitter.